<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21268" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Epstein-Barr Virus</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hoover</surname>
            <given-names>Karla</given-names>
          </name>
          <aff>Philadelphia College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Higginbotham</surname>
            <given-names>Karla</given-names>
          </name>
          <aff>St. Lucie Medical</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Karla Hoover declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Karla Higginbotham declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21268.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Epstein Barr virus (EBV) is a herpesvirus in which over 90% of the population worldwide has been infected. EBV infection can range from asymptomatic to infectious mononucleosis. Complications are rare, but important to recognize. This activity reviews the evaluation and management of the Epstein Barr virus and explains the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology and epidemiology of Epstein Barr virus.</p></list-item><list-item><p>Review the physical exam findings and lab results of patients with Epstein Barr virus.</p></list-item><list-item><p>Outline the treatment options and possible complications of Epstein Barr virus.</p></list-item><list-item><p>Describe the importance of collaboration and communication amongst the interprofessional team to enhance care coordination for patients affected by Epstein Barr virus.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21268&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21268">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21268.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Epstein Barr virus (EBV) is a double-stranded DNA virus that infects B lymphocyte cells. It is in the herpesvirus family and was discovered in 1964.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref><xref ref-type="bibr" rid="article-21268.r2">[2]</xref>&#x000a0;It can cause a variety of diseases and is spread mainly from saliva containing virus-infected epithelial cells.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref><xref ref-type="bibr" rid="article-21268.r3">[3]</xref>&#x000a0;Close to 95% of adults throughout the world have been infected with EBV.<xref ref-type="bibr" rid="article-21268.r2">[2]</xref>&#x000a0;It is a causative agent of infectious mononucleosis. Treatment is generally supportive care.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref></p>
      </sec>
      <sec id="article-21268.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Epstein Barr virus is a herpesvirus with double-stranded DNA enclosed by proteins. The envelope of the virus has glycoproteins, which are important for attachment and entry into the host cells (B cells and epithelial cells). EBV targets B cells by utilizing their molecular machinery to replicate the viral genome. The virus causes B cells to differentiate into memory B cells, which then can move into the circulatory system, or become latent until a trigger causes reactivation.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref></p>
        <p>The transmission of the Epstein Barr virus occurs in several ways, such as deep kissing or food-sharing. Increased levels of viral DNA are found in salivary secretions after the initial infection. Children can be infected after eating food that has already been chewed by an EBV infected individual.<xref ref-type="bibr" rid="article-21268.r3">[3]</xref>&#x000a0;The transmission has occurred through stem cell and organ transplantation, as well as blood transfusion.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref><xref ref-type="bibr" rid="article-21268.r3">[3]</xref></p>
      </sec>
      <sec id="article-21268.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Nearly 95% of the world&#x02019;s population of adults have been infected with the Epstein Barr virus.<xref ref-type="bibr" rid="article-21268.r2">[2]</xref>&#x000a0;In the United States, children and adolescents between the ages of 6&#x000a0;to 19 years had an EBV prevalence of 66.5%. Children between 6-8 years of age had a prevalence of approximately 54%, while adolescents 18-19 years old had a prevalence of 82.9%. More females than males were infected, but the difference was minimal. Children and adolescents who identified as Mexican-American had a higher prevalence of Epstein Barr virus than non-Hispanic Blacks and Whites. There was a higher prevalence of Epstein Barr virus infection in children and adolescents who had larger households, lower household incomes, lower parental education, and who were born outside the U.S.<xref ref-type="bibr" rid="article-21268.r4">[4]</xref>&#x000a0;</p>
        <p>Worldwide prevalence rates of Epstein Barr virus vary. In England, the Epstein Barr virus prevalence rate for children ages 11 to 24 was 74.6%. Younger patients 11&#x000a0;to 14 years old had a lower prevalence rate of Epstein Barr virus when compared to older children. Young adults 22&#x000a0;to 24-year olds had 93% seropositivity.<xref ref-type="bibr" rid="article-21268.r5">[5]</xref>&#x000a0;In a study population from Tehran, Iran, the seroprevalence of Epstein Barr virus IgG antibody was 81.4%. Almost 95% of the subjects over 40 years old were seropositive. The prevalence of seropositive subjects increased as age increased, except for in the infant population. Infants had elevated levels of Epstein Barr virus IgG antibodies that decreased as they aged, likely due to loss of maternal antibodies over time.<xref ref-type="bibr" rid="article-21268.r6">[6]</xref>&#x000a0;In China, a study showed a prevalence rate of greater than 50% before 3 years of age, and over 90% by ages 8&#x000a0;to 9 years old.<xref ref-type="bibr" rid="article-21268.r7">[7]</xref>&#x000a0;</p>
        <p>One study found that the infection rates tend to increase between June and August, most likely due to increased human interaction during the summer months.<xref ref-type="bibr" rid="article-21268.r8">[8]</xref></p>
      </sec>
      <sec id="article-21268.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Determining if a patient has Epstein Barr virus requires a thorough history and physical. Infection with Epstein Barr virus can cause a variety of symptoms, ranging from asymptomatic to a spectrum of illnesses. In children, infection with Epstein Barr virus can often be asymptomatic or present with vague symptoms.<xref ref-type="bibr" rid="article-21268.r2">[2]</xref>&#x000a0;Patients infected with Epstein Barr virus can have systemic manifestations including splenomegaly, lymphadenopathy, headache, malaise, fever, and sore throat.<xref ref-type="bibr" rid="article-21268.r8">[8]</xref>&#x000a0;Patients may show symptoms for several months, with fatigue as the most common lingering complaint. In a study done by Rea et al., physical exam findings such as cervical lymphadenopathy and pharyngitis, were seen at six months after the initial infection in about one-quarter of the study group (n=140). Lab abnormalities such as lymphocytosis, with a presence of atypical lymphocytes, are most common. Liver function tests can also be abnormally elevated. In some patients, there was even a decline in functional and emotional status while they were sick that improved throughout the study period.<xref ref-type="bibr" rid="article-21268.r9">[9]</xref></p>
      </sec>
      <sec id="article-21268.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Determining if a patient has an infection due to Epstein Barr virus is usually most effective through serological testing. Atypical appearing lymphocytosis is most commonly present on peripheral smear.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref>&#x000a0;Heterophile antibody tests identify IgM antibodies against EBV. Heterophile antibody testing is a good initial test since it is inexpensive, fast, and has a sensitivity of 63-84% and specificity of 84&#x000a0;to 100%.<xref ref-type="bibr" rid="article-21268.r2">[2]</xref><xref ref-type="bibr" rid="article-21268.r10">[10]</xref>&#x000a0;The disadvantages of the heterophile antibody test include the possibility of a negative result in children, since they may not produce heterophile antibodies to EBV. Unfortunately, other disease processes can induce heterophile antibodies, or they may be present for over a year, causing a positive result unrelated to an acute EBV infection.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref><xref ref-type="bibr" rid="article-21268.r3">[3]</xref>&#x000a0;Viral capsid antigen (VCA) IgM and IgG can be used to confirm the diagnosis. Elevated levels of VCA IgM antibodies detect an acute infection, while increased VCA IgG antibody levels indicate prior or chronic infection.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref>&#x000a0;Patients with EBV who were followed for 6 months showed VCA-IgM antibodies that subsided after a month and VCA-IgG that decreased over time.<xref ref-type="bibr" rid="article-21268.r9">[9]</xref></p>
      </sec>
      <sec id="article-21268.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Epstein Barr virus is treated symptomatically with medications that can reduce fever and pain.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref>&#x000a0;Some studies using antiviral medications for EBV treatment did show a decrease in the amount of virus shed in the oral cavity, but there was no improvement in overall symptoms.<xref ref-type="bibr" rid="article-21268.r2">[2]</xref>&#x000a0;Corticosteroids are not therapeutic, but they can be beneficial in patients who develop airway compromise or autoimmune complications caused by EBV infection.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref></p>
      </sec>
      <sec id="article-21268.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several other diseases need to be considered as part of the differential diagnosis. Bacterial pharyngitis presents with a sore throat, cervical lymphadenopathy, pharyngeal swelling, and tonsillar exudates. Viral pharyngitis usually includes fatigue, fever, rhinorrhea, or conjunctivitis.<xref ref-type="bibr" rid="article-21268.r11">[11]</xref>&#x000a0;Cytomegalovirus (CMV) is another virus in the <italic toggle="yes">Herpesviridae</italic> family that presents similarly to EBV with a sore throat, fevers, chills, elevated liver function tests, and fatigue. Splenomegaly and lymphadenopathy are less common CMV symptoms.<xref ref-type="bibr" rid="article-21268.r12">[12]</xref>&#x000a0;Acute HIV infection is also on the differential. These patients present with fevers, muscle and joint pain, fatigue, headaches, and sometimes with lymphadenopathy and pharyngitis.<xref ref-type="bibr" rid="article-21268.r13">[13]</xref></p>
      </sec>
      <sec id="article-21268.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Infectious mononucleosis caused by Epstein Barr virus is a self-limiting disease with a relatively good prognosis, as most patients will improve over time.<xref ref-type="bibr" rid="article-21268.r9">[9]</xref>&#x000a0;However, there are complications from having EBV infection, which vary in frequency.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref></p>
      </sec>
      <sec id="article-21268.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Epstein Barr virus has several associated complications. One dangerous complication is splenic rupture due to infectious mononucleosis. In one case study, splenic rupture occurred 6 days after symptoms of infection. It can be treated conservatively or surgically. Pain control and close monitoring are appropriate conservative management strategies reserved for hemodynamically stable patients. Another non-surgical management option is splenic artery embolization. The surgical option is splenectomy which requires post-operative immunizations, antibiotics, and close follow-up.<xref ref-type="bibr" rid="article-21268.r14">[14]</xref>&#x000a0;</p>
        <p>Another complication of infectious mononucleosis from EBV is airway obstruction from tonsillar edema of the pharyngeal tissues. Treatment of airway obstruction includes steroids, tracheotomy, or intubation. Airway obstruction is a rare (1-3.5% of cases) but an important complication of infectious mononucleosis that occurs mostly in children.<xref ref-type="bibr" rid="article-21268.r2">[2]</xref><xref ref-type="bibr" rid="article-21268.r15">[15]</xref><xref ref-type="bibr" rid="article-21268.r16">[16]</xref></p>
        <p>Acute acalculous cholecystitis is a complication that can be treated conservatively with pain medication and antiemetics.<xref ref-type="bibr" rid="article-21268.r17">[17]</xref><xref ref-type="bibr" rid="article-21268.r18">[18]</xref>&#x000a0;In some cases, patients elected to have laparoscopic cholecystectomy due to unbearable abdominal pain.<xref ref-type="bibr" rid="article-21268.r18">[18]</xref></p>
        <p>There are many other complications from Epstein Barr virus infection that can occur, such as myocarditis, encephalitis, hemophagocytic lymphohistiocytosis, pancreatitis, and autoimmune hemolytic anemia.<xref ref-type="bibr" rid="article-21268.r19">[19]</xref><xref ref-type="bibr" rid="article-21268.r20">[20]</xref><xref ref-type="bibr" rid="article-21268.r21">[21]</xref><xref ref-type="bibr" rid="article-21268.r22">[22]</xref>&#x000a0;EBV has also been implicated in causing lymphomas and nasopharyngeal cancers.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref></p>
      </sec>
      <sec id="article-21268.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Infected patients should avoid sharing utensils, drinks, and kissing others since EBV is transmitted through saliva.<xref ref-type="bibr" rid="article-21268.r1">[1]</xref></p>
        <p>Patients in sports should be cleared by a&#x000a0;clinician before resuming activities. A minimum of three weeks and full resolution of splenomegaly is standard to decrease the risk of splenic rupture.<xref ref-type="bibr" rid="article-21268.r2">[2]</xref></p>
      </sec>
      <sec id="article-21268.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with EBV infection should be under the care of an interprofessional team including primary clinicians, nurses, and pharmacists to improve outcomes. As shown in a prospective study done by Rea et al., symptoms can last for several months (Level 5).<xref ref-type="bibr" rid="article-21268.r9">[9]</xref>&#x000a0;Patients should be instructed on what symptoms to expect and for how long to expect them to last. They should be aware of possible complications and when to seek help. Patients who participate in sports need medical clearance and a minimum of three weeks before returning to activities to reduce the risk of splenic rupture.<xref ref-type="bibr" rid="article-21268.r2">[2]</xref></p>
      </sec>
      <sec id="article-21268.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21268&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21268">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/epstein-barr-virus-mononucleosis-or-mono/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21268">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21268/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21268">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21268.s14">
        <fig id="article-21268.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Main symptoms of infectious mononucleosis Contributed by Wikimedia Commons,"Medical gallery of Mikael H&#x000e4;ggstr&#x000f6;m 2014" (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1075px-Main_symptoms_of_Infectious_mononucleosis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21268.s15">
        <fig id="article-21268.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Reactive Lymphocytes, Morphology, Infectious Mononucleosis, peripheral smear Contributed by Ed uthman (CC by 2.0) https://creativecommons.org/licenses/by/2.0/</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Reactive__lymphocytes__b" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21268.s16">
        <fig id="article-21268.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Follicular Conjunctivitis.&#x000a0;Inflammation is noted with viral infections like herpes zoster, Epstein-Barr virus infection, infectious mononucleosis, and chlamydial infections, as well as in reaction&#x000a0;to topical medications and molluscum contagiosum. Follicular conjunctivitis has been described in patients with COVID-19. The inferior and superior tarsal conjunctiva and the fornices show gray-white elevated swellings about 0.5 to 1 mm in diameter and have a velvety appearance. Contributed by Prof. BCK Patel MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Follicular__conjunctivitis-BCK__Patel__MD" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21268.s17">
        <title>References</title>
        <ref id="article-21268.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Odumade</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Hogquist</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Balfour</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Progress and problems in understanding and managing primary Epstein-Barr virus infections.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>193</fpage>
            <page-range>193-209</page-range>
            <pub-id pub-id-type="pmid">21233512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Womack</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Common questions about infectious mononucleosis.</article-title>
            <source>Am Fam Physician</source>
            <year>2015</year>
            <month>Mar</month>
            <day>15</day>
            <volume>91</volume>
            <issue>6</issue>
            <fpage>372</fpage>
            <page-range>372-6</page-range>
            <pub-id pub-id-type="pmid">25822555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunmire</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Verghese</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Balfour</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Primary Epstein-Barr virus infection.</article-title>
            <source>J Clin Virol</source>
            <year>2018</year>
            <month>May</month>
            <volume>102</volume>
            <fpage>84</fpage>
            <page-range>84-92</page-range>
            <pub-id pub-id-type="pmid">29525635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowd</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Palermo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brite</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McDade</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Aiello</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>e64921</fpage>
            <pub-id pub-id-type="pmid">23717674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winter</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>OG</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JEA</given-names>
              </name>
              <name>
                <surname>Stagg</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Predictors of Epstein-Barr virus serostatus in young people in England.</article-title>
            <source>BMC Infect Dis</source>
            <year>2019</year>
            <month>Nov</month>
            <day>28</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>1007</fpage>
            <pub-id pub-id-type="pmid">31779585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharifipour</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davoodi Rad</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Seroprevalence of Epstein-Barr virus among children and adults in Tehran, Iran.</article-title>
            <source>New Microbes New Infect</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>34</volume>
            <fpage>100641</fpage>
            <pub-id pub-id-type="pmid">32025310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiong</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LZ</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>QS</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>YX</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>e99857</fpage>
            <pub-id pub-id-type="pmid">24914816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grotto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Huerta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pitlik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults.</article-title>
            <source>Epidemiol Infect</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>683</fpage>
            <page-range>683-9</page-range>
            <pub-id pub-id-type="pmid">12948368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rea</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Katon</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ashley</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Buchwald</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus.</article-title>
            <source>J Am Board Fam Pract</source>
            <year>2001</year>
            <season>Jul-Aug</season>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>234</fpage>
            <page-range>234-42</page-range>
            <pub-id pub-id-type="pmid">11458965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fugl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr virus and its association with disease - a review of relevance to general practice.</article-title>
            <source>BMC Fam Pract</source>
            <year>2019</year>
            <month>May</month>
            <day>14</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <pub-id pub-id-type="pmid">31088382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vincent</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Celestin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Pharyngitis.</article-title>
            <source>Am Fam Physician</source>
            <year>2004</year>
            <month>Mar</month>
            <day>15</day>
            <volume>69</volume>
            <issue>6</issue>
            <fpage>1465</fpage>
            <page-range>1465-70</page-range>
            <pub-id pub-id-type="pmid">15053411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Cytomegalovirus.</article-title>
            <source>Am Fam Physician</source>
            <year>2003</year>
            <month>Feb</month>
            <day>01</day>
            <volume>67</volume>
            <issue>3</issue>
            <fpage>519</fpage>
            <page-range>519-24</page-range>
            <pub-id pub-id-type="pmid">12588074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Selwyn</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and initial management of acute HIV infection.</article-title>
            <source>Am Fam Physician</source>
            <year>2010</year>
            <month>May</month>
            <day>15</day>
            <volume>81</volume>
            <issue>10</issue>
            <fpage>1239</fpage>
            <page-range>1239-44</page-range>
            <pub-id pub-id-type="pmid">20507048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnwell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deol</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Atraumatic splenic rupture secondary to Epstein-Barr virus infection.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Jan</month>
            <day>24</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">28119438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glynn</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Mackle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kinsella</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Upper airway obstruction in infectious mononucleosis.</article-title>
            <source>Eur J Emerg Med</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-2</page-range>
            <pub-id pub-id-type="pmid">17198326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kakani</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Airway compromise in infectious mononucleosis: a case report.</article-title>
            <source>Cases J</source>
            <year>2009</year>
            <month>Aug</month>
            <day>13</day>
            <volume>2</volume>
            <fpage>6736</fpage>
            <pub-id pub-id-type="pmid">19918540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Young</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lampe</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Primary Epstein-Barr Virus Infection in an Adolescent Female Complicated by Acute Acalculous Cholecystitis.</article-title>
            <source>Cureus</source>
            <year>2019</year>
            <month>Jun</month>
            <day>30</day>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>e5044</fpage>
            <pub-id pub-id-type="pmid">31501735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rezkallah</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Barakat</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Farrah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chalise</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zdunek</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Acute Acalculous Cholecystitis due to primary acute Epstein-Barr virus infection treated with laparoscopic cholecystectomy; a case report.</article-title>
            <source>Ann Med Surg (Lond)</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>35</volume>
            <fpage>189</fpage>
            <page-range>189-191</page-range>
            <pub-id pub-id-type="pmid">30364603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watanabe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Panetta</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Piccirillo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Spoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Serino</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Costantino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Sciascio</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Acute Epstein-Barr related myocarditis: An unusual but life-threatening disease in an immunocompetent patient.</article-title>
            <source>J Cardiol Cases</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>137</fpage>
            <page-range>137-140</page-range>
            <pub-id pub-id-type="pmid">32256861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akkoc</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kadayifci</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Karaaslan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Atici</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yakut</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ocal Demir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soysal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bakir</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr Virus Encephalitis in an Immunocompetent Child: A Case Report and Management of Epstein-Barr Virus Encephalitis.</article-title>
            <source>Case Rep Infect Dis</source>
            <year>2016</year>
            <volume>2016</volume>
            <fpage>7549252</fpage>
            <pub-id pub-id-type="pmid">27213062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x00103;rginean</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Molnar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chince&#x0015f;an</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>e18759</fpage>
            <pub-id pub-id-type="pmid">32011461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21268.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khosla</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A rare case of acute pancreatitis and life-threatening hemolytic anemia associated with Epstein-Barr virus infection in a young healthy adult.</article-title>
            <source>J Infect Public Health</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-101</page-range>
            <pub-id pub-id-type="pmid">26190854</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
